Should You Accumulate Homology Medicines Inc (FIXX) Stock Tuesday Morning?

Tuesday, August 01, 2023 07:43 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Homology Medicines Inc (FIXX) Stock Tuesday Morning?

Homology Medicines Inc (FIXX) is down Tuesday morning, with the stock losing -2.16% in pre-market trading to 1.36. FIXX's short-term technical score of 27 indicates that the stock has traded less bullishly over the last month than 73% of stocks on the market. In the Biotechnology industry, which ranks 117 out of 146 industries, FIXX ranks higher than 38% of stocks. Homology Medicines Inc has risen 56.18% over the past month, closing at $0.88 on July 4. During this period of time, the stock fell as low as $0.84 and as high as $1.38. FIXX has an average analyst recommendation of Buy. The company has an average price target of $8.00.

FIXX has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on FIXX!

See Full FIXX Report

Homology Medicines Inc has a Long-Term Technical rank of 41. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 59% of the market scoring higher. In the Biotechnology industry which is number 129 by this metric, FIXX ranks better than 129% of stocks.

Important Dates for Investors in FIXX:

-Homology Medicines Inc is set to release earnings on 8/21/2023. Over the last 12 months, the company has reported EPS of $-2.18. -We do not have a set dividend date for Homology Medicines Inc at this time. Click Here To Get The Full Report on Homology Medicines Inc (FIXX)